Best TWAS P=3.43e-15 · Best GWAS P=1.63e-15 conditioned to 0.00112
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Brain Cortex | NRBF2 | 0.30 | 0.26 | enet | 24 | 0.21 | 1.4e-06 | 5.7 | 5.8 | 5.2e-09 | -0.52 | 0.82 | 0.12 | FALSE |
2 | GTEx | Brain Frontal Cortex BA9 | NRBF2 | 0.25 | 0.17 | lasso | 6 | 0.16 | 6.1e-05 | -6.8 | 6.6 | 3.1e-11 | -0.55 | 0.53 | 0.08 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | JMJD1C | 0.09 | 0.01 | enet | 18 | 0.07 | 8.6e-06 | 4.2 | 6.1 | 9.7e-10 | -0.41 | 0.37 | 0.09 | FALSE |
4 | GTEx | Esophagus Mucosa | NRBF2 | 0.14 | 0.11 | lasso | 10 | 0.11 | 6.4e-08 | -6.3 | 6.2 | 8.0e-10 | -0.54 | 0.57 | 0.42 | FALSE |
5 | GTEx | Esophagus Muscularis | NRBF2 | 0.10 | 0.03 | enet | 22 | 0.03 | 3.8e-03 | -6.1 | 5.5 | 2.8e-08 | -0.45 | 0.28 | 0.30 | FALSE |
6 | GTEx | Nerve Tibial | NRBF2 | 0.08 | 0.09 | enet | 11 | 0.06 | 5.0e-05 | -6.3 | 6.1 | 1.2e-09 | -0.49 | 0.96 | 0.02 | FALSE |
7 | GTEx | Testis | NRBF2 | 0.14 | 0.08 | lasso | 12 | 0.09 | 6.7e-05 | -6.3 | 6.0 | 1.5e-09 | -0.52 | 0.78 | 0.03 | FALSE |
8 | GTEx | Testis | JMJD1C-AS1 | 0.22 | 0.08 | enet | 23 | 0.10 | 3.7e-05 | 5.9 | 6.3 | 2.7e-10 | -0.37 | 0.67 | 0.04 | FALSE |
9 | GTEx | Thyroid | NRBF2 | 0.11 | 0.05 | lasso | 3 | 0.07 | 2.5e-06 | 4.6 | 5.9 | 3.1e-09 | -0.53 | 0.63 | 0.21 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | NRBF2 | 0.34 | 0.46 | lasso | 5 | 0.46 | 3.1e-66 | -6.8 | 6.7 | 2.3e-11 | -0.55 | 0.98 | 0.02 | FALSE |
11 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | NRBF2 | 0.07 | 0.04 | blup | 42 | 0.02 | 7.3e-03 | -6.7 | 5.8 | 6.7e-09 | -0.42 | 0.11 | 0.13 | FALSE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | NRBF2 | 0.05 | 0.06 | lasso | 2 | 0.06 | 5.5e-12 | -6.8 | 6.9 | 5.7e-12 | -0.55 | 0.50 | 0.50 | FALSE |
13 | The Cancer Genome Atlas | Colon Adenocarcinoma | NRBF2 | 0.13 | 0.10 | enet | 11 | 0.09 | 4.9e-06 | -6.8 | 5.8 | 6.5e-09 | -0.49 | 0.22 | 0.48 | FALSE |
14 | The Cancer Genome Atlas | Glioblastoma Multiforme | JMJD1C | 0.11 | 0.02 | blup | 87 | 0.05 | 1.4e-02 | -6.7 | 7.2 | 4.0e-13 | -0.53 | 0.02 | 0.59 | FALSE |
15 | The Cancer Genome Atlas | Glioblastoma Multiforme | NRBF2 | 0.17 | 0.09 | enet | 10 | 0.13 | 1.1e-04 | -6.8 | 7.1 | 1.0e-12 | -0.51 | 0.08 | 0.33 | FALSE |
16 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | NRBF2 | 0.04 | 0.04 | enet | 5 | 0.03 | 1.3e-04 | -6.7 | 6.1 | 8.8e-10 | -0.51 | 0.22 | 0.21 | FALSE |
17 | The Cancer Genome Atlas | Brain Lower Grade Glioma | NRBF2 | 0.08 | 0.08 | enet | 6 | 0.08 | 4.3e-09 | -6.8 | 6.8 | 1.0e-11 | -0.57 | 0.49 | 0.50 | FALSE |
18 | The Cancer Genome Atlas | Lung Adenocarcinoma | NRBF2 | 0.09 | 0.06 | enet | 8 | 0.07 | 2.7e-08 | -6.7 | 5.9 | 3.7e-09 | -0.50 | 0.50 | 0.48 | FALSE |
19 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | NRBF2 | 0.09 | 0.02 | enet | 6 | 0.04 | 1.4e-05 | 1.8 | 5.1 | 2.9e-07 | -0.50 | 0.40 | 0.36 | FALSE |
20 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | LOC84989 | 0.10 | 0.05 | blup | 19 | 0.04 | 7.7e-03 | 5.9 | 7.1 | 1.2e-12 | -0.44 | 0.01 | 0.38 | FALSE |
21 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | NRBF2 | 0.18 | 0.13 | enet | 11 | 0.08 | 2.5e-04 | -6.7 | 7.9 | 3.4e-15 | -0.73 | 0.04 | 0.90 | TRUE |
22 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | NRBF2 | 0.08 | 0.02 | blup | 40 | 0.04 | 8.6e-03 | -6.8 | 6.3 | 2.3e-10 | -0.43 | 0.03 | 0.07 | FALSE |
23 | The Cancer Genome Atlas | Prostate Adenocarcinoma | NRBF2 | 0.08 | 0.09 | lasso | 6 | 0.08 | 9.7e-09 | -6.7 | 6.4 | 1.6e-10 | -0.52 | 0.50 | 0.50 | FALSE |
24 | The Cancer Genome Atlas | Thyroid Carcinoma | NRBF2 | 0.14 | 0.10 | enet | 16 | 0.09 | 8.1e-09 | -6.7 | 6.9 | 7.0e-12 | -0.45 | 0.52 | 0.48 | FALSE |